A Comparison of the Retropubic (TVT) With the Transobturator Sling Operation in the Treatment of Female Stress Urinary Incontinence or Stress Dominated Mixed Urinary Incontinence

Sponsor
David Scheiner (Other)
Overall Status
Terminated
CT.gov ID
NCT00642109
Collaborator
University of Zurich (Other)
160
1
3
57
2.8

Study Details

Study Description

Brief Summary

The midurethral tension-free vaginal tape (a macroporous polypropylene mesh) procedure is a well established technique for treating female stress urinary incontinence in patients with (hyper)mobile urethra. Postoperative continence rates are achieved in up to 95%. Currently, several anatomical approaches are developed and investigated to simplify this minimal invasive technique and make it safer. While the retropubic approach consists of the passage of the needles from under the midurethra up behind the pubic bone through the cavum retzii, the transobturator technique traverses the foramina obturatoria. Intraoperative complications like bladder perforation (in 4%) can be treated conservatively, while postoperative complications like voiding dysfunction (urinary outlet obstruction in up to 16% or urinary retention) are troublesome, impair the quality of life and require occasionally surgical sling release (transection of the sling). The aim of this study is to compare quality of life, postoperative voiding dysfunction, success rates and tape position after retropubic and transobturator sling procedure.

  • Trial with surgical intervention
Condition or Disease Intervention/Treatment Phase
  • Procedure: midurethral sling procedure
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Clinical Trial: Comparison of the Retropubic (TVT) With the Transobturator (outside-in T.O.T. Monarc or Inside-out TVT-O) Sling Operation in the Treatment of Female Stress Urinary Incontinence or Stress Dominated Mixed Urinary Incontinence
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Sep 1, 2010
Actual Study Completion Date :
Oct 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Other: TVT

Tension-free Vaginal Tape (TVT)

Procedure: midurethral sling procedure
quality of life, voiding dysfunction

Other: TOT

Transobturator Tape outside-in (TOT Monarc)

Procedure: midurethral sling procedure
quality of life, voiding dysfunction

Other: TVT-O

Transobturator Tape inside-out (TVT-O)

Procedure: midurethral sling procedure
quality of life, voiding dysfunction

Outcome Measures

Primary Outcome Measures

  1. Urodynamic stress urinary incontinence measurement [December 2009]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Urodynamic stress urinary incontinence or stress dominated mixed urinary incontinence with mobile urethra

  • With or without concomitant surgery for pelvic organ prolapse

  • With or without hysterectomy

Exclusion criteria:
  • No informed consent

  • No preoperative urodynamic investigation

  • Mixed urinary incontinence with predominant overactive bladder

  • Recurrent stress urinary incontinence after sling procedure

  • Begin of treatment of overactive bladder less then a month ago or non stable condition

  • Pregnancy

  • Desires future childbearing

  • Concomitant incontinence procedure like intravesikal injection of Botulinumtoxin

  • Preoperative postvoid residual urinary volume exceeding 100cc

  • Coagulopathies

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital of Zurich, clinic for gynaecology Zurich Switzerland 8091

Sponsors and Collaborators

  • David Scheiner
  • University of Zurich

Investigators

  • Study Director: 01 Studienregister MasterAdmins, UniversitaetsSpital Zuerich

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David Scheiner, PI, University of Zurich
ClinicalTrials.gov Identifier:
NCT00642109
Other Study ID Numbers:
  • slingrnd06
First Posted:
Mar 24, 2008
Last Update Posted:
Jul 28, 2015
Last Verified:
Jul 1, 2015

Study Results

No Results Posted as of Jul 28, 2015